BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31755786)

  • 1. Evidence for shrunken pore syndrome in children.
    den Bakker E; Gemke RJ; van Wijk JA; Hubeek I; Stoffel-Wagner B; Bökenkamp A
    Scand J Clin Lab Invest; 2020 Feb; 80(1):32-38. PubMed ID: 31755786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of renal function at admission and mortality in hip fracture patients - a single center prospective observational study.
    H Jonsson M; Åkesson A; Hommel A; Grubb A; Bentzer P
    Scand J Clin Lab Invest; 2021 May; 81(3):201-207. PubMed ID: 33606570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.
    Foster MC; Levey AS; Inker LA; Shafi T; Fan L; Gudnason V; Katz R; Mitchell GF; Okparavero A; Palsson R; Post WS; Shlipak MG
    Am J Kidney Dis; 2017 Sep; 70(3):406-414. PubMed ID: 28549536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of GFR in children using rescaled beta-trace protein.
    den Bakker E; Gemke R; Pottel H; van Wijk JAE; Hubeek I; Stoffel-Wagner B; Bökenkamp A
    Clin Chim Acta; 2018 Nov; 486():259-264. PubMed ID: 30121167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C measurement leads to lower metformin dosage in elderly type 2 diabetic patients.
    Šálek T; Adamíková A
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):298-302. PubMed ID: 30218617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options.
    Grubb A
    Clin Biochem; 2020 Sep; 83():12-20. PubMed ID: 32544475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children.
    Filler G; Priem F; Lepage N; Sinha P; Vollmer I; Clark H; Keely E; Matzinger M; Akbari A; Althaus H; Jung K
    Clin Chem; 2002 May; 48(5):729-36. PubMed ID: 11978599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical benefits of using inulin clearance and cystatin C for determining glomerular filtration rate in HIV-1-infected individuals treated with dolutegravir.
    Yukawa S; Watanabe D; Uehira T; Shirasaka T
    J Infect Chemother; 2018 Mar; 24(3):199-205. PubMed ID: 29150412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease.
    Spanaus KS; Kollerits B; Ritz E; Hersberger M; Kronenberg F; von Eckardstein A;
    Clin Chem; 2010 May; 56(5):740-9. PubMed ID: 20224047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of serum beta-trace protein (BTP) measurement in the prediction of glomerular filtration rate. Comparison with serum cystatin C.
    Solichova P; Novackova L; Ochmanova R; Stejskal D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2006 Jul; 150(1):83-4. PubMed ID: 16936905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance between creatinine- and cystatin C-based eGFR in clinical practice.
    den Bakker E; Musters M; Hubeek I; van Wijk JAE; Gemke RJBJ; Bokenkamp A
    Scand J Clin Lab Invest; 2021 Apr; 81(2):142-146. PubMed ID: 33459074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta Trace Protein does not outperform Creatinine and Cystatin C in estimating Glomerular Filtration Rate in Older Adults.
    Ebert N; Koep C; Schwarz K; Martus P; Mielke N; Bartel J; Kuhlmann M; Gaedeke J; Toelle M; van der Giet M; Schuchardt M; Schaeffner E
    Sci Rep; 2017 Oct; 7(1):12656. PubMed ID: 28978997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective glomerular hypofiltration syndrome.
    Quiroga B; Ortiz A; Díez J
    Nephrol Dial Transplant; 2023 Dec; 39(1):10-17. PubMed ID: 37407284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'.
    Grubb A; Lindström V; Jonsson M; Bäck SE; Åhlund T; Rippe B; Christensson A
    Scand J Clin Lab Invest; 2015 Jul; 75(4):333-40. PubMed ID: 25919022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.
    Werner K; Pihlsgård M; Elmståhl S; Legrand H; Nyman U; Christensson A
    Nephron; 2017; 137(1):29-37. PubMed ID: 28407629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.
    Inker LA; Coresh J; Sang Y; Hsu CY; Foster MC; Eckfeldt JH; Karger AB; Nelson RG; Liu X; Sarnak M; Appel LJ; Grams M; Xie D; Kimmel PL; Feldman H; Ramachandran V; Levey AS;
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):69-78. PubMed ID: 28062677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eGFR, cystatin C and creatinine in shrunken pore syndrome.
    Zhou H; Yang M; He X; Xu N
    Clin Chim Acta; 2019 Nov; 498():1-5. PubMed ID: 31398310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating glomerular filtration rate (GFR) in children. The average between a cystatin C- and a creatinine-based equation improves estimation of GFR in both children and adults and enables diagnosing Shrunken Pore Syndrome.
    Leion F; Hegbrant J; den Bakker E; Jonsson M; Abrahamson M; Nyman U; Björk J; Lindström V; Larsson A; Bökenkamp A; Grubb A
    Scand J Clin Lab Invest; 2017 Sep; 77(5):338-344. PubMed ID: 28521564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation.
    Šálek T; Vodička M; Gřiva M
    J Clin Lab Anal; 2020 Oct; 34(10):e23427. PubMed ID: 32716587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities.
    Åkesson A; Lindström V; Nyman U; Jonsson M; Abrahamson M; Christensson A; Björk J; Grubb A
    Scand J Clin Lab Invest; 2020 Sep; 80(5):412-422. PubMed ID: 32459111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.